Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2.
about
Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyHuman health implications of nanomaterial exposureNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesCationic fullerenes are effective and selective antimicrobial photosensitizersDrug delivery and nanoparticles:applications and hazardsTargeted and effective photodynamic therapy for cancer using functionalized nanomaterialsDrug Carrier for Photodynamic Cancer TherapyFunctionalized fullerenes in photodynamic therapyCarbon-Based Materials for Photo-Triggered Theranostic ApplicationsOxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubesNanoparticles and neurotoxicityPhotoinduced membrane damage of E. coli and S. aureus by the photosensitizer-antimicrobial peptide conjugate eosin-(KLAKLAK)2The potential risks of nanomaterials: a review carried out for ECETOCTranscriptional alteration of matrix-related gene expression in cultured human disc cells by nanoparticles of a bismethanophosphonate fullerene.Effects of nanotoxicity on female reproductivity and fetal development in animal modelsApplications of functionalized fullerenes in tumor theranostics.Hybrid photoactive fullerene derivative-ruboxyl nanostructures for photodynamic therapy.Induction of different reactive oxygen species in the skin during various laser therapies and their inhibition by fullerene.Difference in phototoxicity of cyclodextrin complexed fullerene [(gamma-CyD)2/C60] and its aggregated derivatives toward human lens epithelial cells.Photodynamic therapy with decacationic [60]fullerene monoadducts: effect of a light absorbing electron-donor antenna and micellar formulation.Photodynamic therapy with fullerenes.Synthesis and photodynamic effect of new highly photostable decacationically armed [60]- and [70]fullerene decaiodide monoadducts to target pathogenic bacteria and cancer cellsType I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria.Comparative and mechanistic genotoxicity assessment of nanomaterials via a quantitative toxicogenomics approach across multiple species.Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation.Synthesis of decacationic [60]fullerene decaiodides giving photoinduced production of superoxide radicals and effective PDT-mediation on antimicrobial photoinactivationIn vitro and in vivo studies of the utility of dimethyl and diethyl carbaporphyrin ketals in treatment of cutaneous leishmaniasis.Antimicrobial photodynamic therapy with fulleropyrrolidine: photoinactivation mechanism of Staphylococcus aureus, in vitro and in vivo studiesNew photosensitizers for photodynamic therapySynthesis and characterization of positively charged pentacationic [60]fullerene monoadducts for antimicrobial photodynamic inactivationFunctionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanismPhotodynamic therapy with fullerenes in vivo: reality or a dream?Potassium Iodide Potentiates Antimicrobial Photodynamic Inactivation Mediated by Rose Bengal in In Vitro and In Vivo Studies.Phototoxicity and cytotoxicity of fullerol in human lens epithelial cellsFullerene C60 exposure elicits an oxidative stress response in embryonic zebrafish.Nanotechnology safety concerns revisited.Nanoparticles in drug delivery and environmental exposure: same size, same risks?Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies.Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10)Evaluation of extraction methods for quantification of aqueous fullerenes in urine
P2860
Q21223673-6E6F4F9E-A98A-4ACF-BEBE-72551BC903CCQ23922473-AA4E8929-27E3-4375-8D19-F0520E21A1D2Q24536032-9533B51B-18DD-4E10-B7CC-963828231484Q24624250-57A8E49D-3833-428E-8169-D80EA4BBC857Q24655744-8B4D427A-BCE1-4EA5-A29A-7086677CD3ECQ26740575-CFEA601D-3F53-4DCB-BD26-E215F9615F71Q26782780-0F1669CC-B202-4264-94CC-911D32A17448Q26851870-8F053D91-B025-4B61-B015-F39135DA56A0Q28075125-1EA4892A-3388-4EE1-B528-7021C2CBFE09Q28388868-0C8AF2CC-B48A-4453-857E-D74B303C603BQ28392496-10D3E03C-801C-43E0-A6DB-E2A5F059151CQ28540649-2598862E-F3E5-4707-9201-718E2B2AF068Q28767397-76310739-86E5-421F-8D4C-0C23F217DFE0Q30450761-263BF373-BE00-40A3-B756-E12589CE66FCQ30452731-7A6E8B1D-A2BA-4284-9050-7817BB86912CQ30468506-FC7ED8A2-F6F8-404D-90EB-44ADED5638BBQ30634347-C68C2DF3-EDE8-41A8-9108-4EBBDCEB1E04Q31084723-275E0321-6DCC-4924-8F8E-EFF9ED4D695BQ33565924-46C6180A-701A-4BF8-AF31-8219FEDBD854Q33605398-3F73E3B3-58B6-4125-886A-434B894BE2C1Q34104388-B32B2745-D6F5-4985-9A0D-D6DA1D78E0DCQ34237331-AD13BBF2-28A2-4003-BFC2-59B2AE5DD397Q34325328-A47F0F5E-7DDD-4EA6-B909-B7B67BE197D0Q34473335-F9A5A9C2-7CA1-456F-AF3F-98F379945235Q34510513-62397B2B-BFE5-4070-B523-40C8BA604036Q34615580-1A1419B6-8F77-4E28-B5A0-7B40A902B846Q35270608-F639EE4C-CDC2-4F9D-AC5E-A899C3299BC3Q35597701-784DCE74-F7C8-4884-A343-4E55138460D4Q35919257-EE8B938E-DACC-4614-A905-92FF4BDB3F51Q35992839-99A71683-FD89-49D6-90BE-ED421FF65E91Q36017297-9D1B4FD5-3BF5-406F-8AE9-BCE83020E93CQ36206957-47E6C7E6-C14C-4933-8247-230D5AD69A16Q36355741-369C6966-B560-410C-96E4-59CD766DA234Q36606861-4211D436-A691-41BB-8776-D7411CBE3298Q36708956-88D838BA-8D07-4FE1-8E94-728050A482E8Q36865560-53C88857-89F8-45BB-9090-A06782415E09Q36917908-26E126E5-7A59-45E9-AAE1-F3CF6DDE33C0Q36986737-E0465AA3-943D-4914-A7EE-C36903CA801AQ37003300-D896A615-D99B-41B4-8C17-3E3F2DCD87ACQ37012158-840E08E8-DD39-43CB-884B-11F5E4F29CB9
P2860
Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@ast
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@en
Active oxygen species generated from photoexcited fullerene
@nl
type
label
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@ast
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@en
Active oxygen species generated from photoexcited fullerene
@nl
prefLabel
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@ast
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@en
Active oxygen species generated from photoexcited fullerene
@nl
P2093
P356
P1476
Active oxygen species generate ...... al medicines: O2-* versus 1O2.
@en
P2093
Kumi Arakane
Naoki Miyata
Tetsuo Nagano
Toshiki Masumizu
Yoko Yamakoshi
Yukihiro Goda
P304
12803-12809
P356
10.1021/JA0355574
P407
P577
2003-10-01T00:00:00Z